A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma

OBJECTIVE: This study aimed to explore the efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) with ZiLongJin Tablet (ZLJT) in delaying acquired resistance in advanced EGFR-mutant lung adenocarcinoma (LUAD) patients. Furthermore, we employed netwo...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xue, Liang, Lan, He, Chenming, Ren, Qinyou, Su, Jialin, Cao, Liang, Zheng, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664478/
https://www.ncbi.nlm.nih.gov/pubmed/37990309
http://dx.doi.org/10.1186/s12906-023-04213-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664478/
https://www.ncbi.nlm.nih.gov/pubmed/37990309
http://dx.doi.org/10.1186/s12906-023-04213-3

Ejemplares similares